Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older who are admitted to a neurosurgery department for surgery to remove a suspected high-grade brain tumour (grade 3 or 4 glioma) using a special dye called 5-ALA during the operation
- People aged 18 years or older who are admitted to a neurosurgery department for surgery to remove a primary or secondary brain tumour without the use of the 5-ALA dye
- People who have given their written agreement (informed consent) to take part in the study
Who may not be able to join:
- People under the age of 18
- People who are pregnant
- People who are currently in prison
- People with an intellectual disability
- People who have not provided written informed consent before the operation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fady T Charbel, MD, University of Illinois at Chicago
Phone: 312-996-4842
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Demonstrate the increased detection of fluorescence during surgery (performance); Assess the safety and benefit-risk profile versus a legally marketed alternative therapy i.e. visual fluorescence guidance (safety)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.